UNSPSC 51473102: Benzoin

This classification denotes an anti-infective agent with the molecular formula C14H12O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L7J6A1NE81, chemically known as 2-hydroxy-1,2-diphenylethanone but generally known as benzoin, which bears US NIH Compound Identifier 8400. Benzoin comes in many forms, including base, acetate, cyclic butaneboronate, ethyl ether, gum, isobutyl ether, isopropyl ether, methyl ester, methyl ether, n-methylcarbamate, oxime, phenylhydrazone, resin, and tincture.

European Medicines Agency schedules Benzoin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13016MIG. Most nations schedule benzoin under HS 29144000 and SITC 51629. Benzoin bears US NLM identifiers UMLS ID C0005070 and NCI Concept Code C77026. SMILES: OC(C1CCCCC1)C(=O)C1CCCCC1.

UNSPSC 51473102 Benzoin, a Commodity code, represents fragmented purchasing of janitorial supplies, pharmaceuticals, and over-the-counter products across county and state cooperative procurement vehicles. State and local governments acquire these consumable items on an as-needed basis to support ongoing operations at fire rescue departments, public health facilities, and other administrative entities. The issuing bodies span county purchasing offices and state multistate cooperative purchasing alliances, with procurement officers treating benzoin and related chemical compounds as line items within broader janitorial, operational, or pharmaceutical supply solicitations rather than as standalone specialty procurement activities.

Hillsborough County Board of County Commissioners posted ITB 2600319 on July 7, 2026, seeking consumable janitorial and operational supplies for the Hillsborough County Fire Rescue Department with bids due July 24, 2026; the estimated contract value is $765,679.84 for one year, with delivery to the Public Safety Operations Complex in Tampa, Florida. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026, to establish contracts for generic multi-source pharmaceuticals and over-the-counter products across participating state and local government facilities in Minnesota and Oregon, with proposals due March 26, 2026. Recent activity shows procurement concentrated in Florida and the Upper Midwest, though the code's broader geographic reach remains unclear from available opportunities. Vendors responding to these solicitations must meet FDA compliance, cGMP certification, authorized distributor requirements, and delivery timelines ranging from five to ten business days depending on urgency.